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~ Routine High Pressure Poet-Brant Dilatation did Not 
Influence Clinical Reatenoels In 8TARS 
R, Moisten, J,J, Popma, D,~, EIoim. A,J, Lan~;ky, A,~, Ablzald. J,F~ ~aucodo, 
K,M, Kent, L,F, B~tlor, A,D, Piehord. R,E, Kanlz, K, He, M,~, Loon, 
W~]~htngton Ho~ptlal C~ttt~r, W~lltngtot~ OC, USA 
Prior otodio~ I~avo uggogtod o rolational~ip between I~i011 prooouro and ovor- 
~i~od b~llooa dilation and oxco~z~ivo late lumen Io~8 alter coronary _stearin 9
To determine the clinl~al conooquonco of high prooguro dilation on late clinicol 
recurrence ~ltor optimal st~nt p~acomont, we roviowog the cflnical toured of 
1050 p0ti0nt~ onroUod in t!m Stont Antithromboit~ Regimen ~tudy ($TAR~) 
galloon:orlon/ ratlo~ wore dote'mined u~ing quantitative method8 (GM~), 
An injury ~com (l~) wo~ dolinnd o~: 0 (adji.inct PTCA pro~ooro • tO aim & 
balloon:effort/ratio ,. 1, t), f (~dlunot PTCA pmo~um :- 16 o~ balloon nrt~n/ 
retie ~ 1 t, end ~?(adiunct PTCA pro~00r0 o 10 & b~lloon:oftory ratio * 1 t), 
Mm . ~ 7~ 9 ;'6~3 ~5 .:1,95 n valo~ 
Flof~¢}e~¢.,, mm ~.~ -~, 0 2 3 O * 0 1 3 O * O 3 ,0000r 
ML0, p0sl ~ ~, 0,1 ~h, 04 3 0 ,0  5 .00001 
% ~lono~ls, post 1(1, t4 ~O * 13 ~I * 1;~ -0,0001 
13~lloon:itito~y t 3 * 0~ 1 1 ~ O 1 t t  ~ 0 1 • 0.0001 
PR[~,, ~lm 174-.30 17fi,90 177.30 0919 
"~Qnl SIIo R0v~c I~% 11% 4',= .:00001 
A muttlvanoblo model demonstrated that I;nal MLD end vo~ t si~o (OR 
0,431; p • 00001) and nor the Iniu~y score (OR = 0.90: p ~ 0,660) was 
rot(tied to laid TSR, We conclu~o Item STARS, high prossuro post.stent 
balloon dilatabon was not ~ssoclatocl with higher clinical rostenosis rates. 
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~ A  Compsrlson of the Long AVE Micro '" Slant II and 
the Palmaz-~¢hatz '*. ~tent: A SMART Trial Registry 
R. Heuser, R, Kuntz, A, Lansky, KKL. He, L Reduto, R, Bad0er, 
L,A, lannono, P Wt~itlow, R, Vlietstra. Columbia Medical Center, Phoenfx, 
AZ; Beth Israel Oeaconoss Medical Canter, Boston, MA, USA 
Background: The SMART Trial i'~ a prospective, randomized, multicenter, 
comparative thai of the AVE Micro Slant II and the Palmaz-Schatz (P/S) 
slant in do nero and rostenotic coronary lesions up Io 30 mm in lanolin. A 
non-ranclomized regzshy of patients wdh long lesions (mean = ;)2.6 ± 10.1 
mm by QCA) who received the 39 mm AVE MereStent II was also conducted, 
Methods: The data hem the 39 mm AVE Micro Stent II implantations (n 
= 160) wore compared to the data for the PIS steal implantations (n = 331) 
{rom the randomized trial, 
Results: The demographics and 6-month clinical data are: 
Demographics AVE PfS p 
Single vessel disease 8215 I%1 242 (73%) .. 0.001 
Doublo vossoI disease 48 (30%) 70 (~1%) 0,033 
Triple vessel disease 30 (19%) 10 (6%) -0001 
Pno~ MI 66 |42%) t03 (31%) 0025 
Prior CABG 23 (14%) 17 (5%) 0.001 
CCS Ill or IV 109 (68°o) 230 (69%) NS 
HTN (Rx required) 95 (59°°) 190 (58%) NS 
Hyperlip=dornia (R~ req ) 69 (43%) 101 (31%) 0 011 
D~abotos Mett~tus 4 ~ (26°°) 57 (17%) 003 
Lostontength 226 ~- 101 12 1 , 6.2 
Chnical Results A,/E P/S p 
AC.u.te p~ocedur~.t SuCCeS~ 89 4% 94.7¢:o N$ 
TLR 9.2% 81% NS 
Conclusion: In spite of a higher risk population in the AVE group, 6-month 
ett~cacy of the 39 mm AVE stent and the P/S stent were not signilicantly 
different 
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~ T h e  Wsllatont In NMIve Coronary Arlerle= (WIN) 
Multlcenter Randomized Trloh In Hospital Acute 
Results 
L, Bilodooa, T, Schlolbor, J,D, Hilton, $, Rosonblum, 6, MONa, M McIvor, 
Z, Krajc, or, B,H, Wiloon, C, 8snomhi~l, L,D, Beck, A, Podan, Montn~al Heart 
Institute, Montreal, Canada 
Thg WIN study i0 O randomized real comparing th~ c|lnicoI and ~ng!ogr~ghic 
outcome ol balloon angioplasty (BA) tO W~llstent (~T) implantati~, d~nng 
imho~pll~l ~lay and at 6 month (o!low.up~ A total el 464 pts (63 ~ 11 yr, 
7~% male) wet0 randomitsd to either gA (~5)  or ST I_9.L~9) Eighty thrw 
percent of pit  h~d unstable angina and 18% pro~onLed a fOb, LenDIng Ion=on, 
Target Iooi0n typed w0r0 ~6% 01, 41% B~, ~nd 10% C (15% g~la~oitv~li; 
vessels worn': ~% LAD, ~6% CX, and 48% RCA, In the I~A 0reaP, ~5~ ot 
pt~ received a boil Out slant ac¢omJn 9 to stnn!!]ont prowl cnte,~, Pmce~:~r~t 
ao~;~so w-~ 9~),~% in the ST group and 97~8% in tire BA ~coo~J~n~l to the 
aetua! proto¢;ol, Abrupt and suba~mto closure wore ~00fv~-J in 3 a~J ~ pIs 
in the ~T .Proap cqmpar0d tq 4 and 3 pt~ tn !hq E~A g!oup, !Osp~f!veJy (p = 
N~;), 
Conclusi_cm: Acate_ly the W~!lste~nt ts ao otte~livo as baliox)n ~np¢oplasly 
The 6.month c!int(;al follow,up will b~ prose~ntod. 
In.Hospital EvOnts 
EiT m ~- ~99) 0A in ~- ~351 
n (%) n (%i p 
30 d~y de~lh I (Q 4l 1 t0 4t 0 99 
Em GAnG t ta4t ~ (O 0) 0 58 
O MI 0 tO0) t tO 4t 032 
NO MI 16 (70) 12 t5 1 ) a 40 
CVA I (0 4) 0 (0 at 0 31 
CAOG 1 t04) ~ (09) 058 
RO PTCA 6 (~6) 2 to 9t 0 14 
Combined ,~ 19 6t 1315 5) 0 10 
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~ A  MulUcenter Randomized Trial Comparing Five 
Different "l~pes of Slotted-Tube Slents 
J. Hausleiter, J. Dirschinger, H. Sehuhlen. W. Giehd I , H. Walter, J. Pache. 
S. Elezi, A. Wehinger. P Boekstegem ~ . G. Steinbeck ~ , A. Sch0mlg 
Deutsches Herzzentrum & Klinikum rechts dot tsar, TUM. Germany: 
~ Khnikum GreBhadem. LMU: Munich. Germany 
Background: The impact o1 diff,~ront stent designs on procedural success 
and maim adverse cardiac events (MACE) is not known. 
Methods: We conducted a mult~center randomized tnal companng 5 dd- 
ferent commercially available slotted-tube stems. Four stent types tPalmaz- 
Schatz (PS). Jormson & Johnson; NIR, Boston Scienldic: Pure A: Devon 
Medical; ID, Inflow Dynamics) wele implanted as bare stents hand-mounted 
on standard balloon catheters. The Multilink slant tAGS) was used with its 
stent delivery system (SOS). From May 96 until May 97, 1126 patients were 
randomized, By August 97, complete 30-days fellow-up data are available in 
90.5°-0. 
Results: On intention.to.treat basis, overall success rate without MACE at 
30-days follow-up was 946% with PS, 94.7=..o with NIR, 96.6% with Pure A. 
94.3% with ID and 95.6% with ACS. However, in 14% this was only achieved 
alter deploying slants o! other type. 30-day success without MACE, and 
without deployment of stent types other than randomized, was achieved in 
85.9% of PS, 90.3% of NIR, 90.7% Of Pure A, 93.3% of ID and 64.2=0 of 
ACS. Based on the actually implanted steal type, the occ!usion rates were 
1.2% for PS, 2.2°.0 for NIR, 1.8% for Pura A, 2.0% for ID. end 1.4% for ACS 
Conclusions: These preliminan/ data suggest significant differences ;n 
pr- lural success rates, predominantly reflecting differences in trackabtlity. 
t or. MACE and occlusion rates are not significantly different between 
( .~ent typr=s. 
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[ -~-~ Late Quantitative Angiographic Results After NIR 
Stent Use: Results From the NIRVANA Randomized 
Trial and Registries 
A.J. Lansky. J.J. Popma, R. Mehran, J.F. Saucedo, A.S. Abizaid, 
C O'Shaughnessy, J.B. HermiUer. D. Cutlip. i4.E. Kuntz, D.S. Bairn, 
MB Leon. Washington Hospital Center, Washington DC, USA 
The NIR Steal is a novel, stainless steel, continuous weave multiceitular slant 
with 7 (2.5-3,5 mm stents) or 9 (3.5-4.0 mm steals) adaptive cells that confer 
unique flexibility when unexpanded and support and vessel contormability 
when expanded. The clinical safety and efficacy of the NIR stent in de hove 
JACC FchmaD I*~M AII.5'IRAC'15 ih,d 8!A 
(ON) I~,iO~5 W~,~ Ov~Ilt~Itt~(i in ~ fon(}omt~(~l chnloill tn~l with th~ JJIS s.tont: 
ll,~ V~iiUO in Ip~Itll~'Its With a~lJto and lhr@i~l(~n@~l Closure (ACGC)= and for 
d@|@r~i~ tl~ @ally af~@gr~pt~¢ l@Sult~ Of pt~ trO~t,e~J with the NIR =~t¢l~l 
w@ rOvl¢,:-wOcj t~lO clno~n~ogli~m~ n the rafldom~/eq trial and r¢01,~tnes 
tt~ifl 9 q,~ntit~tivo Ix~thoGs (CM~*MEDI~,) The fin-;tl 5tent ~rcJers reS~ZL~ 
13~NIR DN,~Ji5 AC:'fC 5VG 
Flet'er~n~ m,"~ ~96 ~053 303 ~ 053 ;~i9 ~ OBt 348 ~ Ol~ 
~stjl!s to_ ~ _JJl$ ~n ~ ~Ovo ic.~ns; c,~r~ara_~lo acu_to rOsg|t~ were eD= 
t~l~J  in AC~TC and ~VG ~L]~IOU~t~..  f011OW,Up rest~nOsT m fa.tes ,n the 
laP~_@m~O~l !hal will ~ pf0seeted 
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~ Ra_ndom_u~-d Com!~ri_=on f_Lo_Hr Gu=idewbe Ond 
!~k~ha=ni¢~! Ouk,~L~l¥ire'~ for Re],¢onol:_u~otion f 
Chronic To~! Ceroflon/O¢_¢!ulionl; lhe TOTAL_ T~!, 
Fin#l R~tjit and Follow-up at 30 _Day~ 
Patnck W Senuys, Y~enne Teun~sen On !~halt at It~e TOTAL Study 
trv~P.Slzgato~ Erasre~s U~vers~ly R~tte~dam. ~ Ca[d~alys~s Rotterdam 
Ti'z@. Nethertaml.s 
Back_~au~q~ Despite continuous ~pravement al mechanical gmdew=res 
(MW~ for core~,Iry an~optasty, chronic total occlusions (CTO) remain a 
flue challenge. The Spec'ffanebcs laser wire {LW) coroUmes mechanical at- 
mb~es with the ablative ener~ et the CVX-300 e~c=mer laser to lacditate the 
crossing at coronary total ncclusl~na The cunent study compared the laser 
wire to roechaz~cal wires w~th respect to eff~.acy and safety. The pnroary 
e~nt  was treatment success, defined as roaching the true lumen Of ar~ 
branch distal ta the occlusion by the allocated W w~th[n 30 minutes at flue- 
rescopy time A secondary eodpamt was the cress-over treatment success 
(CXS), atte~ m~t]al failure with the allocated W. 
Methods: Patients with angina and/or ischem~a nd an anglegraphically 
documented (~ 1 month] TIMI 0 flow CTO were ehg=ble tar enduslan A total 
el 305 pat]ents (pts] were randomized to e~ther LW or MW m 18 European 
centers. AngregraphJc exclusmn cntena were the absence el any enh~' point 
or the mabihty to vlsualeze the d~stal lumen through collateral c~rculahon. 
Results: In 305 pts Cage 58.8 ~ t0 yrs. previous MIm 56%) the roed=- 
anangtocjraphlc age el ocolus~on was 9 weeks (range 4-269). The m.oclusmn 
length (QCA) was 15 = 9 man. Treatment success, based on intent]ann to 
treat analysts, was 475°o with the ~ and 531% with the LW (p = 0 33) 
The CXS was 45.5°0 after CX to LW and 27.3°0 after CX to MW, as a con- 
sequence the cumulatn, e success m the LW arm was 61 4°0 and 86.3°° m 
the MW arm. The average cumulat]ve success was 63.9% (C.L 585-69.3%), 
whereas the success rate after the =tubal and sole attempt with the MW was 
47.5% (c.L 398-55.2). Complications tallowing the first attempt (death, MI, 
emergency cage,  lamponade) was 0% in the LW arm and 0.6% in the MW 
arm. At I Month, 90.3% of the LW pts and 90.0°0 at the MW pts were event 
tree. LW pts vs MW pts: Death 0% vs 0.6%, MI 4.t°o vs 2.5%: CABG 4.8% 
vs 6.9%: rePTCA 0.7% vs 0%. 
Conclusion. Laser wire technology increases the crossing success rate 
troro 475% (cath lab with MW only) to 63 9% (calh lab with laser wire 
technology), without increasing =he nsk of comphcations. 
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~2-~- ]  Viability Identification Low Dose Pharmacological by 
Stress Echo Predicts Favourable Left Ventricular 
Remodeling Very Early After Acute Myocardial 
Infarction 
S. Polimeno, O. Silvestri. G. Gaeta, M. Bocoalatte, A. Boccalatte, E. Piceno 
Cardiology Division Cardarelli Hospital, Naples: CNR Institute of Clinical 
Physiatogy. Pisa, Italy 
Background: Myocardial stunning may cause a reversible left ventrtcular 
dysfunction after an acute myocardial infarction (AMi) Myocardial viability 
decreases ventricular emodehng. 
~.~lh~ ~3r~ Fl#Sut~5 Tt~itly In=ho~.tEtl 0~t]~ftl~ with AMI (a~e 57 ~ tt 
~.ear~). all tr0~tOd with thromll3otyt~ the f~y~ qF~=~t  (I? ~. 7 r_to~Js t f~  
symptom~ on~t) ~ ~-0 c~ho ~tudy I at bas#!~e# (REST); 2 w~th com~n~ 
v~ry low dose ~pyndamolo (028 mojkgl Ov~.r a)  =m~te .dy  tO.wed by low 
~O~eGobut~mlne (5~=~k~mln in5 }(OIDO); 3 ~lt OIlOW-UO(7(~ystromAM!) 
W010CtiO~) w~ ,~t~,d  tO quantity ond~l~a~tot~ (EDVI ~ ~y~o~_ 
(ESV) votum@~: Th@ wail m~ti~n C=cq~'o irK~~ (V~VI~!) w~,s ~t L:~,~Z~m.@ 179 
0.~' Ol00 fO~-l)~n~_@ iL~n!ihed m,/o~rOi~l vi~l~dity ,p_s (~__r~ 041 WM~I 
:~0 t@~ At f0~t i~,V w~ 40 53. ~ I~44 ml ~nd ~0V w~s 01.27 ~ ~--3,4.~? 
ont~i 0imil~l v~tge_0 t I~iV (41:5 ~ 0,7 t'~ v~ 49,4 z ~1 ~ mtl ~r~ F0V (79 7 
*- 09 ml) whi~ {n~re~od tn "nor~f@s~(~!lii' (O,~' "- t t  ? ml; p ,  0005) 
EDV w~s ~nchangod Ip~th m "re~pon~_ fa" ~!-~! in "non~ro~p0fld#m ~ 
C~¢l~on~: Myocardial Vh!llgllily @v~!g~tC~l vary O~dy ~,t~r AMt with low 
LJ0~0 dipynL:tamo!~.-~!obutammo 5treSS echo grot0¢f_ _sfrqm early qnlav0~Jlal~le 
I011 yen r C'~llaf vO umeth¢ chants  
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~'rho  P:ognostle V~lue of Myocardial Viability 
Re¢ognilE~ by Low Do~e Otpyrl¢l~mole 
Echocardiography In !~¢heml¢ Chronic Left 
Ventrl~u!~r l;)y_ ~functlon 
A Barges A. IDtoodevie.O~k~, W. Mathias, R Bigl, L. Cortigiam, J Hey'man, 
S Pohmeno, C. Baldi, R. ~can, E. P=cano On t~ehaltotthe VIDA (Via~d~ty 
I¢~ant~hc#tion ~i~ D~L:,yn~mote Ado~niE;b'TKJon) E;fu~ly f~'OL.~; CNFI, Inst~!ute 
of Chnical PhysiolOgy, V~a Patio ~avi, Pica, Italy 
The prognosl~c value of myocard~l v i~l i ty  ~ been assessed only in small 
senas, with retros~t=ve analysis co,,-t~ng tram single-centers and L,~sing ow 
dose ~utamme as an mnS',~p~c stress. Aim of this study was to i!sses5 
the prognostic value u~ myo¢~rdml "~=abdity" recognL~d as a contractile 
response to vasuddator et]mulatten i  a large scale, praspechve, multicent0r, 
observat]anal study design. Thus, 240 patients (mean aqe 61 +- 9 years) 
with angiograpPacally proven coronary artery disease, previous ( .3  months) 
m,~ccardial infaretJon and severe LV dysfunction (ejection traction <35%; 
mean: 27 z 9%) were enrolled in a large scale, prespectwe, multicanter, 
oioserval~onal study. Ten laberatanas that had passed quality control for 
stress echo reading entered the proiect. Each patient underwent low dose 
dipyndamole echo (028 mg/Kg in 4:). Myocerd~al vial3it]ty was identdied as 
an ~mprovement ~0.4 m wall motion score index, each segment scÜred from 
I = normal to 4 = dyskmet]c in a 16 segment model of left vanthcle Patients 
were tallowed up tar 6 ~ 6 months (range 1 to 12 months), Seventy patients 
were revasculanzed: cardiac death occurred in none of the 10 patients with 
and =n 7 at the 60 patients without myocardial viability (0 vs 18%). In the 
medically treated pahents, cardiac death occurred in 1 out ot the 13 patients 
w~tn and in t 3 nut of the t 56 patienls w~thout myocardial viability (7% vs 8'%). 
Thus u, severe LV ischem=c dysfunction, the documentation af myocardial 
viability by low dose dipyndamole echo is associated with improved surwval 
only in revasculanzed patients. 
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~~']  Contractile Microvascular Integrity and Cell Reserve, 
Membrane Integrity for Predicting Contractile 
Recovery After Recanalization in Acute Myocardial 
Infarction 
J. Kwan. LY Hyun t , W. Choi ~ , S.W. Cho, K. Park. S.K. Cho. W H Lee 
'Cardiology Dw#s~on, Nuclear Medicine: Inha Unl;'ers~ Inchon. Korea 
Low dose dobutamine stress echncardiagraphy (Dee) can assess contmctdo 
reserve while Myocardial contrast echocard=ography (MCE) and z0, TI SPECT 
('~°'TI) can assess microvascular and cell membrane inlegnty. Which one is 
the best predictor of contractde recovery of the infarcted segment after re- 
canilizatJon of the infarct related aden/ (IRA) in acute myocardial infarction 
(AMI)? The aim of this study was to compare the role of contractile reserve. 
mirovascufar integrity and celt membrane integh~y in predic~ir~ o3nt,~,il~ 
recovery. 16 patients with AMI underwent DSE. MCE and ;mTI shortly at- 
tar recanatizat]on of IRA without Ilow limiting residual stenosis. DSE was 
started with 5 ug/kg/mm the increased up to 20 ug]k~min gegional wall 
motion was assessed with 16 segment model of ASE and wasll mot]on 
score (WMS) was gradeo as 1 (normal), 2 (mild to moderate hypokinesia). 
3 (severe hypokmesm) 4 (alunesia). 5 (dyskmesia). The improvement of 
WMS more than 1 dunng Dee was considered to have contract]le reserve. 
MCE was pedormed with intracorona~/injection of sonicated Hexabnx (3--5 
co). MCE perfusion was graded by semi.quant]tative score (0. 0.5. 1) with 
16 segment model. The segmenls scored as 0.5 or 1 were considered to 
have microvascular integnty. Event patient underwent follow up echocar- 
diography to assess the recovery of wall motion 1 month later. Out of 72 
